although the risk of a patient with phm requiring chemotherapy for gestational trophoblastic tumour is of the order of 1 in 200 , compared with 1 in 12 after a complete mole , there is no justification for excluding a patient from follow-up after the evacuation of a phm .
C0020217
phm
C0678213
complete mole